Mantle cell lymphoma in the ocular adnexal region

Ophthalmology

Volumn 112, Issue 1, 2005, Pages 114-119

  Looi, Audrey ^a,b   Gascoyne, Randy D ^c   Chhanabhai, Mukesh ^c   Connors, Joseph M ^d   Rootman, Jack ^a   White, Valerie A ^a  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d Division of Medical Oncology   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; CD20 ANTIGEN; CD3 ANTIGEN; CD5 ANTIGEN; CYCLIN D1; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD3; PROTEIN P53;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SMEAR; BONE MARROW METASTASIS; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; EYE TUMOR; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MANTLE CELL LYMPHOMA; PLASMACYTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYCLIN D1; EYE NEOPLASMS; EYELID NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LACRIMAL APPARATUS DISEASES; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; ORBITAL NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 11344278499     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2004.07.025     Document Type: Article

References (34)

1. S.H. Swerdlow, M.E. Williams From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades Hum Pathol 33 2002 7 20
2. D.D. Weisenburger Mantle cell lymphoma D.M. Knowles Neoplastic Hematopathology 1992 Williams & Wilkins Baltimore, MD 617 628
3. R.A. Shivdasani, J.L. Hess, A.T. Skarin, G.S. Pinkus Intermediate lymphocytic lymphoma: clinical and pathological features of a recently characterized subtype of non-Hodgkin's lymphoma J Clin Oncol 11 1993 802 811
4. F. Berger, P. Felman, A. Sonet Nonfollicular small B-cell lymphomas: a heterogeneous group of patients with distinct clinical features and outcome Blood 83 1994 2829 2835
5. J.R. Anderson, J.O. Armitage, D.D. Weisenburger Non-Hodgkin's Lymphoma Classification Project Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations Ann Oncol 9 1998 717 720
6. The Non-Hodgkin's Lymphoma Classification Project A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma Blood 89 1997 3909 3918
7. E. Zucca, S. Fontana, E. Roggero Treatment and prognosis of centrocytic (mantle cell) lymphoma: a retrospective analysis of twenty-six patients treated in one institution Leuk Lymphoma 13 1994 105 110
8. A.J. Norton, J. Matthews, V. Pappa Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20-year period Ann Oncol 6 1995 249 256
9. G.A. Velders, J.C. Kluin-Nelemans, C.J. De Boer Mantle cell lymphoma: a population-based clinical study J Clin Oncol 14 1996 1269 1274
10. L.H. Argatoff, J.M. Connors, R.J. Klasa Mantle cell lymphoma: a clinicopathologic study of 80 cases Blood 89 1997 2067 2078
11. F. Bosch, A. Lopez-Guillermo, E. Campo Mantle cell lymphoma Presenting features, response to therapy, and prognostic factors Cancer 82 1998 567 575
12. C.S. Chim, A.C. Chan, C.K. Choo Mantle cell lymphoma in the Chinese: clinicopathological features and treatment outcome Am J Hematol 59 1998 295 301
13. W.L. White, J.A. Ferry, N.L. Harris, A.S. Grove Jr Ocular adnexal lymphoma A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type Ophthalmology 102 1995 1994 2006
14. S.E. Coupland, L. Krause, H.J. Delecluse Lymphoproliferative lesions of the ocular adnexa Analysis of 112 cases Ophthalmology 105 1998 1430 1441
15. M. Cahill, C. Barnes, P. Moriarty Ocular adnexal lymphoma--comparison of MALT lymphoma with other histologic types Br J Ophthalmol 83 1999 742 747
16. C. Jenkins, G.E. Rose, C. Bunce Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival Br J Ophthalmol 84 2000 907 913
17. C. Auw-Haedrich, S.E. Coupland, A. Kapp Long-term outcome of ocular adnexal lymphoma subtyped according to the REAL classification Br J Ophthalmol 85 2001 63 69
18. T. Mannami, T. Yoshino, K. Oshima Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of MALT lymphoma and reactive lymphoid hyperplasia Mod Pathol 14 2001 641 649
19. P.A. McKelvie, A. McNab, I.C. Francis Ocular adnexal lymphoproliferative disease: a series of 73 cases Clin Exp Ophthalmol 29 2001 387 393
20. The International Non-Hodgkin's Lymphoma Prognostic Factors Project A predictive model for aggressive non-Hodgkin's lymphoma N Engl J Med 329 1993 987 994
21. G. Tolksdorf, H. Stein, K. Lennert Morphological and immunological definition of a malignant lymphoma derived from germinal-centre cells with cleaved nuclei (centrocytes) Br J Cancer 41 1980 168 182
22. M. Engelhard, P. Meusers, G. Brittinger Prospective multicenter trial for the response-adapted treatment of high-grade malignant non-Hodgkin's lymphomas: updated results of the COP-BLAM/IMVP-16 protocol with randomized adjuvant radiotherapy Ann Oncol 2 suppl 1991 177 180
23. R. Gerard-Marchant, I. Hamlin, K. Lennert Classification of non-Hodgkin's lymphomas Lancet 2 1974 406 408
24. P.M. Banks, J. Chan, M.L. Cleary Mantle cell lymphoma A proposal for unification of morphologic, immunologic, and molecular data Am J Surg Pathol 16 1992 637 640
25. E. Zucca, H. Stein, B. Coiffier European Lymphoma Task Force (ELTF) Report of the workshop on Mantle Cell Lymphoma (MCL) Ann Oncol 5 1994 507 511
26. N.L. Harris, E.S. Jaffe, H. Stein A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group Blood 84 1994 1361 1392
27. E.S. Jaffe N.L. Harris H. Stein J.W. Vardiman World Health Organisation Classification of Tumours. Pathology & Genetics of Tumours of Haematopoietic and Lymphoid Tissues 2001 IARC Press Lyon, France
28. P. Lardelli, M.A. Bookman, J. Sundeen Lymphocytic lymphoma of intermediate differentiation Morphologic and immunophenotypic spectrum and clinical correlations Am J Surg Pathol 14 1990 752 763
29. M.J. Duggan, D.D. Weisenburger, Y.L. Ye Mantle zone lymphoma A clinicopathologic study of 22 cases Cancer 66 1990 522 529
30. A. Majlis, W.C. Pugh, M.A. Rodriguez Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants J Clin Oncol 15 1997 1664 1671
31. D.C. Louie, K. Offit, R. Jaslow p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32) Blood 86 1995 2892 2899
32. T.C. Greiner, M.J. Moynihan, W.C. Chan p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis Blood 87 1996 4302 4310
33. P. Meusers, J. Hense Management of mantle cell lymphoma Ann Hematol 78 1999 485 494
34. J.P. Leonard, E.J. Schattner, M. Coleman Biology and management of mantle cell lymphoma Curr Opin Oncol 13 2001 342 347